<DOC>
	<DOCNO>NCT01020526</DOCNO>
	<brief_summary>The main purpose study evaluate long-term safety pregabalin adolescent patient participate previous fibromyalgia study ( A0081180 ) wish recieve open-label pregabalin</brief_summary>
	<brief_title>Pregabalin In Adolescent Patients With Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients must meet inclusion criterion precede fibromyalgia Study A0081180 , receive pregabalin/placebo doubleblind condition . Patients may participate study experience serious adverse event previous fibromyalgia study A0081180 determine related study medication investigator sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>